Is polyethylene glycol (PEG) safe to use for treating constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Polyethylene Glycol (PEG) for Constipation: Safety and Efficacy

Polyethylene glycol (PEG) is a safe and effective treatment for constipation and is strongly recommended as a first-line osmotic laxative. 1

Safety Profile

  • PEG has an excellent safety profile with minimal systemic absorption, making it suitable for most patients 1
  • PEG works as an osmotic laxative that draws water into the intestine to soften stool and increase bowel movements 1
  • Unlike other laxatives, PEG causes virtually no net gain or loss of sodium and potassium, making it safer for long-term use 1
  • The only absolute contraindication is allergy to polyethylene glycol 2
  • Common side effects are generally mild and include bloating, abdominal discomfort, and cramping 1

Efficacy

  • PEG is strongly endorsed in systematic reviews of chronic constipation 1
  • The American Gastroenterological Association strongly recommends PEG over management without PEG for chronic idiopathic constipation (strong recommendation, moderate certainty of evidence) 1
  • Response to PEG has been shown to be durable over 6 months with no evidence of tachyphylaxis (diminished response over time) 3
  • Long-term studies have demonstrated safety and efficacy for up to 12 months of continuous use 3

Dosing Considerations

  • Standard initial dose is 17g daily, which can be titrated based on symptom response 1
  • There is no clear maximum dose, allowing for flexibility in treatment 1
  • For acute constipation relief within 24 hours, higher doses (e.g., 68g) may be used safely for short-term treatment 4
  • PEG is relatively inexpensive ($10-$45 monthly) compared to prescription constipation medications 1

Special Populations

  • PEG is considered safe in elderly patients with no significant changes in electrolytes even with prolonged use 3
  • PEG has been shown to be safe and effective in children, including infants under 18 months of age 5, 6
  • PEG is preferred over lactulose for chronic constipation in both adults and children, showing better outcomes in stool frequency, stool form, and relief of abdominal pain 7

Clinical Advantages Over Other Laxatives

  • PEG is more effective than lactulose, which has a latency of 2-3 days before onset of effect and commonly causes nausea and abdominal discomfort 1, 7
  • Unlike magnesium salts, PEG doesn't pose a risk of hypermagnesemia, even with prolonged use 1
  • PEG is preferred over bulk laxatives in opioid-induced constipation 1
  • PEG is more effective and has fewer side effects than liquid paraffin, which can cause lipoid pneumonia, anal seepage, and skin excoriation 1

Implementation in Practice

  • PEG can be used as first-line therapy or after a trial of fiber supplementation for mild constipation 1
  • Ensure adequate hydration when using PEG, as with all osmotic laxatives 1
  • For chronic constipation, daily maintenance therapy may be required rather than as-needed dosing 3
  • If PEG alone is insufficient, combination therapy with stimulant laxatives may be considered for refractory cases 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Overnight efficacy of polyethylene glycol laxative.

The American journal of gastroenterology, 2002

Research

Role of Polyethylene Glycol in the Treatment of Functional Constipation in Children.

Journal of pediatric gastroenterology and nutrition, 2017

Research

Polyethylene glycol for constipation in children younger than eighteen months old.

Journal of pediatric gastroenterology and nutrition, 2004

Research

Lactulose versus Polyethylene Glycol for Chronic Constipation.

The Cochrane database of systematic reviews, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.